These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 18845525)

  • 1. A multicenter phase I trial of interferon-beta and temozolomide combination therapy for high-grade gliomas (INTEGRA Study).
    Wakabayashi T; Kayama T; Nishikawa R; Takahashi H; Yoshimine T; Hashimoto N; Aoki T; Kurisu K; Natsume A; Ogura M; Yoshida J
    Jpn J Clin Oncol; 2008 Oct; 38(10):715-8. PubMed ID: 18845525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter phase I trial of combination therapy with interferon-β and temozolomide for high-grade gliomas (INTEGRA study): the final report.
    Wakabayashi T; Kayama T; Nishikawa R; Takahashi H; Hashimoto N; Takahashi J; Aoki T; Sugiyama K; Ogura M; Natsume A; Yoshida J
    J Neurooncol; 2011 Sep; 104(2):573-7. PubMed ID: 21327711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temozolomide in the treatment of recurrent malignant glioma.
    Chang SM; Theodosopoulos P; Lamborn K; Malec M; Rabbitt J; Page M; Prados MD
    Cancer; 2004 Feb; 100(3):605-11. PubMed ID: 14745879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
    Chang SM; Prados MD; Yung WK; Fine H; Junck L; Greenberg H; Robins HI; Mehta M; Fink KL; Jaeckle KA; Kuhn J; Hess K; Schold C
    Cancer; 2004 Apr; 100(8):1712-6. PubMed ID: 15073861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiles predicting the response to IFN-β and a combination of temozolomide and IFN-β in malignant gliomas.
    Yoshino A; Tashiro S; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Sano E; Tsumoto K
    Int J Oncol; 2011 Sep; 39(3):529-42. PubMed ID: 21805051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour study.
    Hargrave D; Geoerger B; Frappaz D; Pietsch T; Gesner L; Cisar L; Breazna A; Dorman A; Cruz-Martinez O; Fuster JL; Rialland X; Icher C; Leblond P; Ashley D; Perilongo G; Elliott M; English M; Clausen N; Grill J
    J Neurooncol; 2013 May; 113(1):127-34. PubMed ID: 23459995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of palliative treatment with temozolomide in patients with high-grade gliomas.
    Ziobro M; Rolski J; Grela-Wojewoda A; Zygulska A; Niemiec M
    Neurol Neurochir Pol; 2008; 42(3):210-5. PubMed ID: 18651326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma.
    Reardon DA; Quinn JA; Rich JN; Desjardins A; Vredenburgh J; Gururangan S; Sathornsumetee S; Badruddoja M; McLendon R; Provenzale J; Herndon JE; Dowell JM; Burkart JL; Newton HB; Friedman AH; Friedman HS
    Cancer; 2005 Oct; 104(7):1478-86. PubMed ID: 16088964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Central nervous system glioma. Multi-drug chemotherapy including temozolomide].
    Wakabayashi T
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):938-40. PubMed ID: 19579330
    [No Abstract]   [Full Text] [Related]  

  • 10. Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
    Brandes AA; Tosoni A; Basso U; Reni M; Valduga F; Monfardini S; Amistà P; Nicolardi L; Sotti G; Ermani M
    J Clin Oncol; 2004 Dec; 22(23):4779-86. PubMed ID: 15570079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic history of low-grade gliomas before and after temozolomide treatment.
    Ricard D; Kaloshi G; Amiel-Benouaich A; Lejeune J; Marie Y; Mandonnet E; Kujas M; Mokhtari K; Taillibert S; Laigle-Donadey F; Carpentier AF; Omuro A; Capelle L; Duffau H; Cornu P; Guillevin R; Sanson M; Hoang-Xuan K; Delattre JY
    Ann Neurol; 2007 May; 61(5):484-90. PubMed ID: 17469128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma.
    Kocher M; Kunze S; Eich HT; Semrau R; Müller RP
    Strahlenther Onkol; 2005 Mar; 181(3):157-63. PubMed ID: 15756519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma.
    McConville P; Hambardzumyan D; Moody JB; Leopold WR; Kreger AR; Woolliscroft MJ; Rehemtulla A; Ross BD; Holland EC
    Clin Cancer Res; 2007 May; 13(10):2897-904. PubMed ID: 17504989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-beta, MCNU, and conventional radiotherapy for pediatric patients with brainstem glioma.
    Ohno M; Natsume A; Fujii M; Ito M; Wakabayashi T
    Pediatr Blood Cancer; 2009 Jul; 53(1):37-41. PubMed ID: 19260101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation.
    Schiff D
    Cancer Invest; 2007 Dec; 25(8):776-84. PubMed ID: 17952745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas].
    Mizumatsu S; Matsumoto K; Maeda Y; Tamiya T; Furuta T; Ohmoto T
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2055-60. PubMed ID: 9838907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of radiobiologic parameters and equivalent radiation dose of cytotoxic chemotherapy in malignant glioma.
    Jones B; Sanghera P
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):441-8. PubMed ID: 17324531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temozolomide in newly diagnosed malignant gliomas: administered concomitantly with radiotherapy, and thereafter as consolidation treatment.
    Yaman E; Buyukberber S; Uner A; Coskun U; Akmansu M; Benekli M; Yamac D; Ozturk B; Kaya AO; Yildiz R; Ozkan S; Gunel N
    Onkologie; 2008 Jun; 31(6):309-13. PubMed ID: 18547971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temozolomide chemotherapy in patients with recurrent malignant gliomas.
    Yang SH; Kim MK; Lee TK; Lee KS; Jeun SS; Park CK; Kang JK; Kim MC; Hong YK
    J Korean Med Sci; 2006 Aug; 21(4):739-44. PubMed ID: 16891823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.
    Quinn JA; Desjardins A; Weingart J; Brem H; Dolan ME; Delaney SM; Vredenburgh J; Rich J; Friedman AH; Reardon DA; Sampson JH; Pegg AE; Moschel RC; Birch R; McLendon RE; Provenzale JM; Gururangan S; Dancey JE; Maxwell J; Tourt-Uhlig S; Herndon JE; Bigner DD; Friedman HS
    J Clin Oncol; 2005 Oct; 23(28):7178-87. PubMed ID: 16192602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.